长期使用糖皮质激素是围手术期并发症的独立危险因素
基于美国国家手术质量改进计划数据库2008-2016年524万余名手术患者,其中3.5%术前至少30天使用糖皮质激素。经倾向性评分匹配和双重调整逻辑回归后,长期使用糖皮质激素与手术并发症增加和手术结局较差相关。
要点
- 长期使用糖皮质激素显著增加再入院、再手术和死亡风险。
- 术前应评估长期使用糖皮质激素情况并尽可能干预。
- 该关联在控制合并症和人口学差异后仍显著。
核心结论
- 在控制合并症和人口学差异后,长期使用糖皮质激素的患者围手术期结局显著更差。
研究设计与样本
- 回顾性队列研究,查询美国国家手术质量改进计划数据库2008-2016年数据。
- 共纳入5,244,588例符合标准的手术患者,其中181,901例(3.5%)术前至少30天使用糖皮质激素。
- 采用卡方检验和t检验比较,并行倾向性评分匹配及双重调整逻辑回归分析。
主要发现
- 长期使用糖皮质激素的患者合并症显著多于其余人群。
- 长期使用糖皮质激素使住院超过30天的风险增加19%。
- 长期使用糖皮质激素使30天内再入院风险增加58%。
- 长期使用糖皮质激素使再手术风险增加21%。
- 长期使用糖皮质激素使死亡风险增加32%。
临床怎么用
- 术前应评估患者长期使用糖皮质激素的情况,并尽可能在术前加以处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Corticosteroid use continues to rise nationally. Studies have evaluated the impact of chronic steroid use on surgical outcomes in smaller populations. This study investigated the impact of chronic steroid use on perioperative surgical outcomes in a surgical cohort of more than 5 million surgical patients, using a statistically rigorous methodology. METHODS: The National Surgical Quality Improvement Program Database was queried 2008-2016 to evaluate chronic steroid use. Patient demographics, comorbidities, and outcomes were compared, using χ2 and t test analysis, and then repeated after propensity score matching. Finally, a double-adjustment logistic regression was utilized, yielding odds ratios to assess the effect of chronic steroids on perioperative outcomes within the matched population. RESULTS: Between 2008 and 2016, a total of 5,244,588 patients met inclusion criteria, of whom 181,901 (3.5%) were taking steroids for a minimum of 30 days before surgery. Patients on chronic steroids had significantly more comorbidities compared with the remaining population. After propensity score matching and double-adjusted logistic regression, chronic steroid use was found to be associated with increased surgical complications and poorer surgical outcomes. Chronic steroid use significantly increased a patient's risk of having a hospital stay longer than 30 days by 19%, risk of readmission within 30 days by 58%, risk of reoperation by 21%, and risk of death by 32%. CONCLUSION: After controlling for differences in comorbidities and demographics, patients on chronic steroids have significantly poorer perioperative outcomes. Chronic steroid use should be evaluated and, if possible, addressed before surgery, given their significant impact on surgical outcomes.
引用
- Chouairi F, Torabi SJ, Mercier MR, et al. Chronic steroid use as an independent risk factor for perioperative complications. Surgery. 2019. PMID: 30765140. doi:10.1016/j.surg.2018.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。